SIREN : 821431434
MD FORME ET SANTE is a French company founded 9 years ago, specialized in the sector Soins de beauté. Based in MOULINS-LES-METZ (57160), this company of category PME shows in 2020 a revenue of 545 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|
| Revenue | 545 143 € | 585 422 € | 584 431 € | 643 686 € |
| Net income | 11 450 € | -21 715 € | 11 520 € | 35 578 € |
| EBITDA | 10 631 € | -23 382 € | 14 075 € | 40 374 € |
| Net margin | 2.1% | -3.7% | 2.0% | 5.5% |
In 2020, MD FORME ET SANTE achieves revenue of 545 k€. Revenue is declining over the period 2017-2020 (CAGR: -5.4%). Slight decline of -7% vs 2019. After deducting consumption (302 k€), gross margin stands at 243 k€, i.e. a rate of 45%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 11 k€, representing 2.0% of revenue. Positive scissor effect: EBITDA margin improves by +5.9 pts, sign of improved operational efficiency. The operating margin remains fragile, requiring cost vigilance. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 11 k€, i.e. 2.1% of revenue. This profit can be retained or distributed to shareholders.
545 143 €
243 035 €
10 631 €
12 030 €
11 450 €
1.9%
The debt ratio (= Financial debt / Equity x 100) stands at 263%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 22%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 3.7 years of cash flow to repay all financial debt. This ratio remains within usual banking standards. Cash flow represents 2.2% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment.
263.011%
22.364%
2.212%
3.731
58.7%
In 2020, the debt ratio of MD FORME ET SANTE (263.01) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2020, the financial autonomy of MD FORME ET SANTE (22.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2020, the repayment capacity of MD FORME ET SANTE (3.73) ranks in the top 25% of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A long duration may signal heavy debt relative to repayment capacity.
The liquidity ratio (= Current assets / Current liabilities) stands at 139.96. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 5.4x. Operating income very largely covers interest expenses: high safety margin.
139.961
5.446
In 2020, the liquidity ratio of MD FORME ET SANTE (139.96) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
In 2020, the interest coverage of MD FORME ET SANTE (5.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 87 days. Excellent situation: suppliers finance 87 days of the operating cycle (retail model). Inventory turnover is 55 days (= Average inventory / Cost of goods x 360). WCR is negative (-36 days): operations structurally generate cash.
-54 781 €
0 j
87 j
55 j
-36 j
Based on 128 transactions of similar company sales in 2020, the value of MD FORME ET SANTE is estimated at 123 802 € (range 70 183€ - 194 254€). With an EBITDA of 10 631€, the sector multiple of 4.8x is applied. The price/revenue ratio is 0.50x (in line with sector norms). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 128 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare MD FORME ET SANTE with other companies in the same sector:
The revenue of MD FORME ET SANTE in 2020 is 545 k€.
Yes, MD FORME ET SANTE generated a net profit of 11 k€ in 2020.
The headquarters of MD FORME ET SANTE is located in MOULINS-LES-METZ (57160), in the department Moselle.
The tax return of MD FORME ET SANTE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
MD FORME ET SANTE operates in the sector Soins de beauté (NAF code 96.02B). See the 'Sector positioning' section above to compare the company with its competitors.